本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Bone Biologics Corp

0.6601
-0.0200-2.94%
盤後0.66010.00000.00%17:37 EDT
成交量:9,059.00
成交額:6,040.56
市值:215.92萬
市盈率:-0.14
高:0.6801
開:0.6801
低:0.6500
收:0.6801
資料載入中...
2024/03/02

SEC問詢函

Form CORRESP - Correspondence
2024/03/01

重要事件披露

Form 8-K - Current report
2024/03/01

SEC問詢函

Form CORRESP - Correspondence
2024/02/29

SEC問詢函

Form CORRESP - Correspondence
2024/02/28

SEC問詢函

Form CORRESP - Correspondence
2024/02/26

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/23

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/21

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/30

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/01/23

SEC問詢函

Form CORRESP - Correspondence
2024/01/13

重要事件披露

Form 8-K - Current report
2024/01/11

重要事件披露

Form 8-K - Current report
2024/01/10

重要事件披露

Form 8-K - Current report
2024/01/03

重要事件披露

Form 8-K - Current report
2023/12/21

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/18

重要事件披露

Form 8-K - Current report
2023/12/13

重要事件披露

Form 8-K - Current report